Browse studies

Find your next paid study

1 recruiting study matching your filters

Open-Label Study of SPI-1005 for the Treatment of Meniere's Disease

Study of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermit…

Meniere's DiseaseMénière's Disease

Sound Pharmaceuticals, IncorporatedNCT06859788